デフォルト表紙
市場調査レポート
商品コード
1425581

吸入抗生物質の世界市場(2024年)

Inhaled Antibiotics Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
吸入抗生物質の世界市場(2024年)
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の吸入抗生物質の市場規模は近年力強く成長しています。2023年の14億6,000万米ドルから2024年には15億8,000万米ドルへと、CAGR7.8%で拡大すると予測されています。過去の期間に見られた拡大は、規制当局の支援や承認、全身投与から標的投与への移行、抗生物質耐性の増加、呼吸器感染症の増加など、さまざまな要因によるものです。

2023年の吸入抗生物質市場シェアでは北米が最大地域でした。吸入抗生物質市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 吸入抗生物質市場の特徴

第3章 吸入抗生物質市場の動向と戦略

第4章 吸入抗生物質市場:マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の吸入抗生物質市場の規模と成長

  • 世界の吸入抗生物質市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の吸入抗生物質の市場規模の実績と成長(2018年~2023年)
  • 世界の吸入抗生物質の市場規模の予測と成長(2023年~2028年、2033年)

第6章 吸入抗生物質市場セグメンテーション

  • 世界の吸入抗生物質市場:製品タイプ別、実績および予測(2018年~2023年、2023年~2028年、2033年)
  • エアゾールまたは定量吸入器
  • ドライパウダー製剤
  • 噴射
  • その他のタイプ
  • 世界の吸入抗生物質市場:用途別、実績および予測(2018年~2023年、2023年~2028年、2033年)
  • 肺炎
  • 喘息
  • 気管支炎
  • その他の用途
  • 世界の吸入抗生物質市場:エンドユーザー別、実績および予測(2018年~2023年、2023年~2028年、2033年)
  • 病院
  • その他のエンドユーザー

第7章 吸入抗生物質市場:地域・国別分析

  • 世界の吸入抗生物質市場:地域別、実績および予測(2018年~2023年、2023年~2028年、2033年)
  • 世界の吸入抗生物質市場:国別、実績および予測(2018年~2023年、2023年~2028年、2033年)

第8章 アジア太平洋の吸入抗生物質市場

第9章 中国の吸入抗生物質市場

第10章 インドの吸入抗生物質市場

第11章 日本の吸入抗生物質市場

第12章 オーストラリアの吸入抗生物質市場

第13章 インドネシアの吸入抗生物質市場

第14章 韓国の吸入抗生物質市場

第15章 西欧の吸入抗生物質市場

第16章 英国の吸入抗生物質市場

第17章 ドイツの吸入抗生物質市場

第18章 フランスの吸入抗生物質市場

第19章 イタリアの吸入抗生物質市場

第20章 スペインの吸入抗生物質市場

第21章 東欧の吸入抗生物質市場

第22章 ロシアの吸入抗生物質市場

第23章 北米の吸入抗生物質市場

第24章 米国の吸入抗生物質市場

第25章 カナダの吸入抗生物質市場

第26章 南米の吸入抗生物質市場

第27章 ブラジルの吸入抗生物質市場

第28章 中東の吸入抗生物質市場

第29章 アフリカの吸入抗生物質市場

第30章 吸入抗生物質市場の競合情勢と企業プロファイル

  • 吸入抗生物質市場の競合情勢
  • 吸入抗生物質市場の企業プロファイル
    • Gilead Sciences Inc.
    • Lupin Limited
    • Insmed Inc.
    • Savara Inc.
    • Joincare Pharmaceutical Group Industry Co. Ltd.

第31章 世界の吸入抗生物質市場の競合ベンチマーキング

第32章 世界の吸入抗生物質市場の競合ダッシュボード

第33章 吸入抗生物質市場の主要な合併と買収

第34章 吸入抗生物質市場の将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12812

Inhaled Antibiotics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhaled antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhaled antibiotics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inhaled antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Aerosol or Metered Dose Inhaler; Dry Powder Formulation; Spray; Other Types
  • 2) By Application: Pneumonia; Asthma; Bronchitis; Other Applications
  • 3) By End-User: Hospitals; Other End Users
  • Companies Mentioned: Gilead Sciences Inc.; Lupin Limited; Insmed Inc.; Savara Inc.; Joincare Pharmaceutical Group Industry Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Inhaled antibiotics serve as medication specifically targeted for respiratory issues, effectively enhancing survival rates and contributing to improvements in lung function. These medications have proven instrumental in delaying lung function deterioration, extending intervals between exacerbations, and elevating overall quality of life.

Diverse types of inhaled antibiotics are available, including aerosol or metered dose inhalers, dry powder formulations, sprays, and other variations. The metered-dose inhaler (MDI) stands as a frequently utilized device for delivering inhaled respiratory medications. These antibiotics find applications across a spectrum of respiratory conditions like pneumonia, asthma, bronchitis, among others, catering to the needs of hospitals and various other healthcare settings.

The inhaled antibiotics market research report is one of a series of new reports from The Business Research Company that provides inhaled antibiotics market statistics, including inhaled antibiotics industry global market size, regional shares, competitors with an inhaled antibiotics market share, detailed inhaled antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the inhaled antibiotics industry. This inhaled antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhaled antibiotics market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in the historical period can be credited to various factors, including regulatory support and approvals, a transition from systemic to targeted delivery methods, an increase in antibiotic resistance, and a rise in respiratory infections.

The inhaled antibiotics market size is expected to see strong growth in the next few years. It will grow to $2.18 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. Anticipated growth in the forecast period can be attributed to several factors such as increased investments in research and development, a wider range of clinical applications, a growing emphasis on personalized medicine, advancements in drug formulations, and ongoing concerns regarding antibiotic resistance. Key trends expected in this period include sustained innovation in formulations, an approach centered around patients' needs, heightened research in respiratory health, a transition toward targeted therapies, and advancements in drug delivery systems.

The anticipated rise in respiratory diseases is poised to drive the growth of the inhaled antibiotics market. These conditions impair lung and airway function, affecting individuals' breathing. Inhaled antibiotics play a crucial role in enhancing lung function, staving off deterioration, extending periods between exacerbations, and improving the quality of life for patients with conditions like cystic fibrosis. Statistics reported by the Australian Institute of Health and Welfare revealed a notable increase in respiratory disease-related deaths in Australia in 2021, totaling 46,551. Similarly, data from The Lancet in September 2022 showcased a 9.50% rise in new cases of respiratory syncytial virus (RSV) during the 2021 summer, underscoring the escalating incidence of respiratory ailments that directly influences the inhaled antibiotics market.

The escalating demand within hospital settings is anticipated to propel the expansion of the inhaled antibiotics market. Hospitals, dedicated to providing medical care to the ill or injured, rely on inhaled antibiotics for managing respiratory infections. These medications help minimize disruptions to gut microbiota, customize treatment approaches, improve patient adherence, and reduce hospitalization rates. As per information from gov.wales in October 2022, NHS bed occupancy rose to 81.2% in 2021-22, marking an 11.8 percentage point increase from the previous year, indicative of the heightened reliance on healthcare facilities. This surge in hospital demand significantly influences the growth trajectory of inhaled antibiotics.

A prominent trend within the inhaled antibiotics market is the substantial investments directed towards their development. Pharmaceutical giants, exemplified by Enbiotix's $11 million investment in December 2021, are actively funding the development of antibiotics tailored for lung infections. These investments focus on clinical testing for medications like murepavadin and ColiFin, specifically targeting patients with cystic fibrosis (CF). Such initiatives underscore the commitment of major pharmaceutical entities towards advancing treatment options for respiratory ailments.

Innovative products like Breyna are being strategically introduced by major players in the inhaled antibiotics market to drive revenue growth. Breyna, an inhalation aerosol combining formoterol fumarate dihydrate and budesonide, effectively manages symptoms associated with asthma and persistent lung diseases. Viatris Inc., in partnership with Kindeva Drug Delivery L.P., successfully launched Breyna in July 2023. This FDA-approved generic version of AstraZeneca's Symbicort is supplied as a metered-dose inhaler and comes in two strengths, catering to patients' varying needs, reflecting the market's focus on innovation and tailored therapeutic solutions.

In August 2021, Philip Morris International Inc., a US-based tobacco company, acquired OtiTopic for an undisclosed sum. This acquisition aligns with PMI's strategic goal of broadening its portfolio of inhaled therapies and respiratory medication delivery. Utilizing its expertise, scientific knowledge, and inhalation capabilities beyond nicotine, PMI aims to expand its offerings in this domain. OtiTopic, a US-based respiratory drug development company specializing in inhaled antibiotics, now operates under the umbrella of Philip Morris International Inc.

Major companies operating in the inhaled antibiotics market report are Gilead Sciences Inc., Lupin Limited, Insmed Inc., Savara Inc., Joincare Pharmaceutical Group Industry Co. Ltd., Pharmaxis Ltd., Teva Pharmaceutical Industries Ltd., Raptor Pharmaceutical Corporation, Altan Pharma Limited, Cipla Limited, Maya Biotech Pvt. Ltd., Medisol Lifescience Pvt. Ltd., Nivon Specialties, Sentiss Pharma Pvt. Ltd., Ultratech India Limited, Midas Care Pharmaceuticals Pvt. Ltd., Precept Pharma Ltd., Luckys Pharma, Novartis AG, Bayer AG, Pfizer Inc., Grifols SA, Vertex Pharmaceuticals Inc., Aridis Pharmaceuticals, Bayer HealthCare, Nektar Therapeutics, Parion Sciences Inc., Zambon Group, Transave Inc., Alitair Pharmaceuticals, Synspira Therapeutics Inc., AIT Therapeutics Inc., Polyphor AG, Oppilan Pharma Ltd., OptiNose Inc.

North America was the largest region in the inhaled antibiotics market share in 2023. The regions covered in the inhaled antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the inhaled antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inhaled antibiotics market consists of sales of jet nebulizers, ultrasonic nebulizers, mesh inhalers, and soft mist inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Inhaled Antibiotics Market Characteristics

3. Inhaled Antibiotics Market Trends And Strategies

4. Inhaled Antibiotics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Inhaled Antibiotics Market Size and Growth

  • 5.1. Global Inhaled Antibiotics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Inhaled Antibiotics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Inhaled Antibiotics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inhaled Antibiotics Market Segmentation

  • 6.1. Global Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Aerosol or Metered Dose Inhaler
  • Dry Powder Formulation
  • Spray
  • Other Types
  • 6.2. Global Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pneumonia
  • Asthma
  • Bronchitis
  • Other Applications
  • 6.3. Global Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Other End Users

7. Inhaled Antibiotics Market Regional And Country Analysis

  • 7.1. Global Inhaled Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Inhaled Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inhaled Antibiotics Market

  • 8.1. Asia-Pacific Inhaled Antibiotics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inhaled Antibiotics Market

  • 9.1. China Inhaled Antibiotics Market Overview
  • 9.2. China Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inhaled Antibiotics Market

  • 10.1. India Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inhaled Antibiotics Market

  • 11.1. Japan Inhaled Antibiotics Market Overview
  • 11.2. Japan Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inhaled Antibiotics Market

  • 12.1. Australia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inhaled Antibiotics Market

  • 13.1. Indonesia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inhaled Antibiotics Market

  • 14.1. South Korea Inhaled Antibiotics Market Overview
  • 14.2. South Korea Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inhaled Antibiotics Market

  • 15.1. Western Europe Inhaled Antibiotics Market Overview
  • 15.2. Western Europe Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inhaled Antibiotics Market

  • 16.1. UK Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inhaled Antibiotics Market

  • 17.1. Germany Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inhaled Antibiotics Market

  • 18.1. France Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inhaled Antibiotics Market

  • 19.1. Italy Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inhaled Antibiotics Market

  • 20.1. Spain Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inhaled Antibiotics Market

  • 21.1. Eastern Europe Inhaled Antibiotics Market Overview
  • 21.2. Eastern Europe Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inhaled Antibiotics Market

  • 22.1. Russia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inhaled Antibiotics Market

  • 23.1. North America Inhaled Antibiotics Market Overview
  • 23.2. North America Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inhaled Antibiotics Market

  • 24.1. USA Inhaled Antibiotics Market Overview
  • 24.2. USA Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inhaled Antibiotics Market

  • 25.1. Canada Inhaled Antibiotics Market Overview
  • 25.2. Canada Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inhaled Antibiotics Market

  • 26.1. South America Inhaled Antibiotics Market Overview
  • 26.2. South America Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inhaled Antibiotics Market

  • 27.1. Brazil Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inhaled Antibiotics Market

  • 28.1. Middle East Inhaled Antibiotics Market Overview
  • 28.2. Middle East Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inhaled Antibiotics Market

  • 29.1. Africa Inhaled Antibiotics Market Overview
  • 29.2. Africa Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inhaled Antibiotics Market Competitive Landscape And Company Profiles

  • 30.1. Inhaled Antibiotics Market Competitive Landscape
  • 30.2. Inhaled Antibiotics Market Company Profiles
    • 30.2.1. Gilead Sciences Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Lupin Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Insmed Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Savara Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Joincare Pharmaceutical Group Industry Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Inhaled Antibiotics Market Competitive Benchmarking

32. Global Inhaled Antibiotics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inhaled Antibiotics Market

34. Inhaled Antibiotics Market Future Outlook and Potential Analysis

  • 34.1 Inhaled Antibiotics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Inhaled Antibiotics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Inhaled Antibiotics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer